Open access · CC-BY
via OpenAlex
Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges
Fukun Chen, NaNa Chen, Chunjuan Xia, Hongyue Wang, Lishi Shao, Chen Zhou, Jiaping Wang
Cell Transplantation · 2023 · ▲ 48 citations
Abstract
Kidney disease (KD) is a life-threatening disease characterized by high morbidity and mortality in clinical settings, which can be caused by many reasons, and the incidence increases with age. However, supportive therapy and kidney transplantation still have limitations in alleviating KD progression. Recently, mesenchymal stem cells (MSCs) have shown great potential in repairing injury through their multidirectional differentiation and self-renewal ability. Of note, MSCs serve as a safe and effective therapeutic strategy for treating KD in preclinical and clinical trials. Functionally, MSCs ameliorate KD progression by regulating the immune response, renal tubular cell apoptosis, tubular epithelial-mesenchymal transition, oxidative stress, angiogenesis, and so on. In addition, MSCs exhibit remarkable efficacy in both acute kidney injury (AKI) and chronic kidney disease (CKD) through paracrine mechanisms. In this review, we outline the biological characteristics of MSCs, discuss the efficacy and mechanisms of MSCs-based therapy for KD, summarize the completed and ongoing clinical trials, as well as analyze limitations and new strategies, aiming to provide new ideas and approaches for the preclinical experiments and clinical trials of MSCs transplantation for KD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1177/09636897231164251
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Chen, F., Chen, N., Xia, C., Wang, H., Shao, L., Zhou, C., & Wang, J. (2023). Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges. <em>Cell Transplantation</em>. https://doi.org/10.1177/09636897231164251
Vancouver
Chen F, Chen N, Xia C, Wang H, Shao L, Zhou C, et al. Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges. Cell Transplantation. 2023. doi:10.1177/09636897231164251.
BibTeX
@article{fukun2023Mesenc,
title = {Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges},
author = {Fukun Chen and NaNa Chen and Chunjuan Xia and Hongyue Wang and Lishi Shao and Chen Zhou and Jiaping Wang},
journal = {Cell Transplantation},
year = {2023},
doi = {10.1177/09636897231164251},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Revista da Associação Médica Brasileira 2020
Open access · CC-BY
Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives
Libyan Journal of Medical Research 2025
Open access · CC-BY
Klotho gene transfection into mesenchymal stem cells as a potential therapy for kidney disease
Human Cell 2014
Open access · CC-BY
Mesenchymal stem cell therapy and acute graft-versus-host disease: a review
Pharmaceutics 2021
Open access · CC-BY
Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease
World Journal of Stem Cells 2014
Open access · CC-BY
Enhancing the efficacy of mesenchymal stem cell therapy
Expert Opinion on Biological Therapy 2023
Preprint · OA